Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000504118 | SCV000595129 | uncertain significance | not specified | 2016-02-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763798 | SCV000894712 | uncertain significance | Diabetes mellitus type 1; Type 1 diabetes mellitus 20; Maturity-onset diabetes of the young type 3; Type 2 diabetes mellitus; Hepatic adenomas, familial; Nonpapillary renal cell carcinoma | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000983927 | SCV001131976 | likely benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000983927 | SCV001772737 | likely benign | not provided | 2021-03-27 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002329195 | SCV002601721 | benign | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs374306837 with MODY3. |